TARGET SKIN LESION

TARGET SKIN LESION was reported 114 times

TARGET SKIN LESION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vesicular Monoamine Transporter 2 Inhibitor [EPC] 1 0.0008
1 Oxytocic [EPC] 1 0.0003
2 Proteasome Inhibitor [EPC] 8 0.0001
3 Anticholinergic [EPC] 1 0.0001
4 Glycopeptide Antibacterial [EPC] 4 0.0001
5 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
6 Mood Stabilizer [EPC] 11 0.0001
7 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
8 Nitroimidazole Antimicrobial [EPC] 3 0.0000
9 Serotonin-3 Receptor Antagonist [EPC] 6 0.0000
10 Anti-epileptic Agent [EPC] 8 0.0000
11 Leukocyte Growth Factor [EPC] 5 0.0000
12 Provitamin D2 Compound [EPC] 1 0.0000
13 Atypical Antipsychotic [EPC] 13 0.0000
14 Vitamin D [EPC] 8 0.0000
15 Aldosterone Antagonist [EPC] 4 0.0000
16 Polyene Antifungal [EPC] 1 0.0000
17 Vitamin B12 [EPC] 8 0.0000
18 Vitamin C [EPC] 9 0.0000
19 Insulin [EPC] 1 0.0000
20 Aminosalicylate [EPC] 2 0.0000
21 Platinum-based Drug [EPC] 5 0.0000
22 Factor Xa Inhibitor [EPC] 5 0.0000
23 Thalidomide Analog [EPC] 9 0.0000
24 Microtubule Inhibitor [EPC] 2 0.0000
25 Proton Pump Inhibitor [EPC] 7 0.0000
26 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
27 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
29 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
30 Corticosteroid [EPC] 13 0.0000
31 Acetylcholine Release Inhibitor [EPC] 1 0.0000
32 Interleukin-23 Antagonist [EPC] 1 0.0000
33 Antirheumatic Agent [EPC] 1 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
35 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
36 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
37 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
38 Osmotic Laxative [EPC] 2 0.0000
39 Loop Diuretic [EPC] 3 0.0000
40 Platelet Aggregation Inhibitor [EPC] 3 0.0000
41 RANK Ligand Inhibitor [EPC] 1 0.0000
42 Alkylating Drug [EPC] 1 0.0000
43 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
44 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
45 Kinase Inhibitor [EPC] 2 0.0000
46 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
47 Benzodiazepine [EPC] 2 0.0000